Pulse Biosciences
PLSE
45 hedge funds and large institutions have $32.4M invested in Pulse Biosciences in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 0 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
21% more capital invested
Capital invested by funds: $26.8M → $32.4M (+$5.61M)
7% more funds holding
Funds holding: 42 → 45 (+3)
0.21% more ownership
Funds ownership: 9.9% → 10.1% (+0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$262K |
| 2 |
State Street
Boston,
Massachusetts
|
+$250K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$218K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$137K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$74.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Griffin Asset Management
New York
|
-$121K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$71.3K |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$28.1K |
| 4 |
Barclays
London,
United Kingdom
|
-$21.5K |
| 5 |
Bank of New York Mellon
New York
|
-$14.9K |
PLSE Hedge Fund Activity: Q3 2019 in Review
45 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2019, worth a combined $32.4M — up 21% from $26.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PLSE positions and 0 closed out — a net gain of 4 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $262K. The largest seller was Griffin Asset Management, cutting an estimated $121K.
- 45 institutional investors held Pulse Biosciences (PLSE) as of Q3 2019, up from 42 in Q2 2019.
- Funds reported $32.4M of Pulse Biosciences stock for Q3 2019, up 21% quarter-over-quarter.
- 4 funds opened new Pulse Biosciences positions in Q3 2019 and 0 closed out, a net change of +4 holders.
- The largest Pulse Biosciences buyer in Q3 2019 was BlackRock, an estimated $262K added.
- The largest Pulse Biosciences seller in Q3 2019 was Griffin Asset Management, an estimated $121K sold.
Based on aggregated 13F filings for Q3 2019.